HealthEquity, Inc. (NASDAQ:HQY) Receives $103.83 Consensus Target Price from Analysts

Shares of HealthEquity, Inc. (NASDAQ:HQY - Get Free Report) have been given a consensus recommendation of "Buy" by the twelve research firms that are currently covering the firm, MarketBeat reports. Twelve analysts have rated the stock with a buy recommendation. The average 12-month price objective among analysts that have covered the stock in the last year is $103.83.

A number of analysts have recently weighed in on HQY shares. Royal Bank of Canada restated an "outperform" rating and issued a $92.00 price objective on shares of HealthEquity in a research note on Wednesday, September 4th. Deutsche Bank Aktiengesellschaft increased their price target on shares of HealthEquity from $102.00 to $103.00 and gave the company a "buy" rating in a report on Wednesday, September 4th. JMP Securities restated a "market outperform" rating and set a $105.00 price objective on shares of HealthEquity in a report on Wednesday, September 4th. Bank of America cut their price objective on shares of HealthEquity from $105.00 to $100.00 and set a "buy" rating for the company in a research report on Wednesday, September 4th. Finally, Barrington Research reissued an "outperform" rating and set a $105.00 target price on shares of HealthEquity in a research report on Friday, September 20th.

Insider Activity

In other HealthEquity news, Director Frank Corvino sold 1,247 shares of the company's stock in a transaction that occurred on Tuesday, October 1st. The shares were sold at an average price of $80.26, for a total value of $100,084.22. Following the completion of the sale, the director now owns 4,823 shares of the company's stock, valued at approximately $387,093.98. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, Director Robert W. Selander sold 8,250 shares of the business's stock in a transaction that occurred on Wednesday, October 9th. The stock was sold at an average price of $82.98, for a total value of $684,585.00. Following the completion of the transaction, the director now directly owns 54,719 shares in the company, valued at approximately $4,540,582.62. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Frank Corvino sold 1,247 shares of the firm's stock in a transaction that occurred on Tuesday, October 1st. The stock was sold at an average price of $80.26, for a total transaction of $100,084.22. Following the sale, the director now owns 4,823 shares in the company, valued at $387,093.98. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 44,497 shares of company stock valued at $3,579,769 in the last ninety days. 2.20% of the stock is owned by insiders.

Institutional Trading of HealthEquity

A number of institutional investors have recently modified their holdings of the company. Vanguard Group Inc. increased its stake in HealthEquity by 1.7% in the 1st quarter. Vanguard Group Inc. now owns 8,768,632 shares of the company's stock valued at $715,783,000 after buying an additional 149,133 shares during the last quarter. Wasatch Advisors LP increased its position in shares of HealthEquity by 8.3% in the first quarter. Wasatch Advisors LP now owns 7,409,080 shares of the company's stock valued at $604,803,000 after acquiring an additional 569,249 shares during the last quarter. Motley Fool Asset Management LLC grew its stake in HealthEquity by 3,001.0% in the first quarter. Motley Fool Asset Management LLC now owns 3,762,064 shares of the company's stock valued at $307,097,000 after purchasing an additional 3,640,748 shares in the last quarter. Clearbridge Investments LLC grew its stake in HealthEquity by 1.9% in the second quarter. Clearbridge Investments LLC now owns 2,377,204 shares of the company's stock valued at $204,915,000 after purchasing an additional 43,491 shares in the last quarter. Finally, Mackenzie Financial Corp increased its position in shares of HealthEquity by 16.0% during the 2nd quarter. Mackenzie Financial Corp now owns 2,364,521 shares of the company's stock worth $203,822,000 after purchasing an additional 325,906 shares during the last quarter. 99.55% of the stock is currently owned by institutional investors.

HealthEquity Trading Down 0.1 %

Shares of NASDAQ:HQY traded down $0.13 during midday trading on Tuesday, reaching $87.61. The company had a trading volume of 335,379 shares, compared to its average volume of 613,145. The company has a fifty day simple moving average of $79.44 and a two-hundred day simple moving average of $79.57. The firm has a market cap of $7.62 billion, a price-to-earnings ratio of 95.23, a price-to-earnings-growth ratio of 1.31 and a beta of 0.52. The company has a debt-to-equity ratio of 0.51, a quick ratio of 4.10 and a current ratio of 4.10. HealthEquity has a 1-year low of $61.81 and a 1-year high of $89.23.

HealthEquity (NASDAQ:HQY - Get Free Report) last posted its quarterly earnings results on Tuesday, September 3rd. The company reported $0.66 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.50 by $0.16. HealthEquity had a net margin of 9.61% and a return on equity of 9.01%. The business had revenue of $299.93 million during the quarter, compared to analyst estimates of $284.48 million. Research analysts predict that HealthEquity will post 2.27 earnings per share for the current year.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.